PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24688953-8	2013	RESULTS: Supplementation with inulin caused a significant reduction in FBS (8.50%), HbA1c (10.40%), total cholesterol (12.90%), triglyceride (23.60 %), LDL-c (35.30 %), LDL-c/HDL-c ratio (16.25%) and TC/HDL-c ratio (25.20%) and increased HDL-c (19.90%).	Carbon	37-38	component of oligomeric golgi complex 2	Homo sapiens	152-157	
25670360-7	2015	CO resulted in significantly larger least-squares mean % changes (all P < .001 vs EVOO) from baseline in LDL-C -10.9 vs -3.5, total-C -8.2 vs -1.8, non-HDL-C -9.3 vs -1.6, and total-C/HDL-C -4.4 vs 0.5.	Carbon	0-1	component of oligomeric golgi complex 2	Homo sapiens	108-113	
24688953-8	2013	RESULTS: Supplementation with inulin caused a significant reduction in FBS (8.50%), HbA1c (10.40%), total cholesterol (12.90%), triglyceride (23.60 %), LDL-c (35.30 %), LDL-c/HDL-c ratio (16.25%) and TC/HDL-c ratio (25.20%) and increased HDL-c (19.90%).	Carbon	37-38	component of oligomeric golgi complex 2	Homo sapiens	169-174	
20686417-4	2010	Niacin is a unique lipid-lowering medication with a capacity to lower low-density lipoprotein cholesterol (LDL-c), triglyceride and increase HDL-c.	Carbon	3-4	component of oligomeric golgi complex 2	Homo sapiens	107-112	
21122658-8	2010	Clinical concordance between D-LDL-C and C-LDL-C was present in 40% of patients, whereas clinical discordance was noted in 25%.	Carbon	0-1	component of oligomeric golgi complex 2	Homo sapiens	31-36	
21122658-8	2010	Clinical concordance between D-LDL-C and C-LDL-C was present in 40% of patients, whereas clinical discordance was noted in 25%.	Carbon	0-1	component of oligomeric golgi complex 2	Homo sapiens	43-48	
21475854-2	2009	It is characterized by abdominal obesity, elevated blood pressure, atherogenic dyslipidemia [high LDL-c (low density lipoprotein cholesterol) and low HDL-c (high density lipoprotein cholesterol)] and insulin resistance or glucose intolerance.	Carbon	6-7	component of oligomeric golgi complex 2	Homo sapiens	98-103	
17389467-8	2007	There were significant improvements in TG (P=0.009), TC (P=0.0001), LDL-c (P=0.019) and TC/HDL-c ratio (P=0.001), and a similar trend in HDL-c levels (P=0.069).	Carbon	18-19	component of oligomeric golgi complex 2	Homo sapiens	68-73	
9568739-5	1998	The HCD+3, HCD+10, HCD+30 and CSTY lowered plasma TC (25, 32, 34 and 32%, respectively), VLDL-C (62, 74, 71 and 75%, respectively), LDL-C (25, 38, 47 and 46%, respectively) and TG (48, 47, 42 and 45%, respectively).	Carbon	5-6	component of oligomeric golgi complex 2	Homo sapiens	90-95